MiR-200a inhibits tumor proliferation by targeting AP-2γ in neuroblastoma cells

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 11, 2014, Pages 4671-4676

  Gao, Shun Li ^a   Wang, Li Zhong ^a   Liu, Hai Ying ^a   Liu, Dan Li ^a   Xie, Li Ming ^a   Zhang, Zhi Wei ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

AP 2 ; Cell proliferation; MiR 200a; Neuroblastoma

Indexed keywords

3' UNTRANSLATED REGION; MESSENGER RNA; MICRORNA; MIRN200 MICRORNA, HUMAN; TFAP2C PROTEIN, HUMAN; TRANSCRIPTION FACTOR AP 2;

3' UNTRANSLATED REGION; ANIMAL; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MOUSE; NEUROBLASTOMA; NUDE MOUSE; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; MICRORNAS; NEUROBLASTOMA; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-2;

EID: 84903737547     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.11.4671     Document Type: Article

References (39)

1. Adam L, Zhong M, Choi W, et al (2009). miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clin Cancer Res, 15, 5060-72.
2. Bai JX, Yan B, Zhao ZN, et al (2013). Tamoxifen represses miR-200 microRNAs and promotes epithelial-to-mesenchymal transition by up-regulating c-Myc in endometrial carcinoma cell lines. Endocrinology, 154, 635-45.
3. Bracken CP, Gregory PA, Kolesnikoff N, et al (2008). A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res, 68, 7846-54.
4. Bushati N, Cohen SM (2007). microRNA functions. Annu Rev Cell Dev Biol, 23, 175-205.
5. Chakrabarti M, Banik NL, Ray SK (2013). miR-138 overexpression is more powerful than hTERT knockdown to potentiate apigenin for apoptosis inneuroblastoma in vitro and in vivo. Exp Cell Res, 19, 1575-85.
6. Chen X, Pan M, Han L, et al (2013). miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a. FEBS Lett, 587, 3729-37.
7. Cochrane DR, Howe EN, Spoelstra NS, Richer JK (2010). Loss of miR-200c: a marker of aggressiveness and chemoresistance in female reproductive cancers. J Oncol, 56, 8217-27.
8. Davis BN, Hata A (2010). microRNA in Cancer The involvement of aberrant microRNA biogenesis regulatory pathways. Genes Cancer, 1, 1100-14.
9. Du Y, Xu Y, Ding L, et al (2009). Down-regulation of miR-141 in gastric cancer and its involvement in cell growth. J Gastroenterol, 44, 556-61.
10. Dykxhoorn DM, Wu Y, Xie H, et al (2009). miR-200 enhances mouse breast cancer cell colonization to form distant metastases. PLoS One, 4, 7181.
11. Eckert D, Buhl S, Weber S, Jager R, Schorle H (2005). The AP-2 family of transcription factors. Genome Biol, 6, 213-46.
12. Gabriely G, Yi M, Narayan RS, et al (2011). Human glioma growth is controlled by microRNA-10b. Cancer Res, 71, 3563-72.
13. Gee JM, Eloranta JJ, Ibbitt JC, et al (2009). Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival. J PathoL, 217, 32-41.
14. Gregory PA, Bert AG, Paterson EL, et al (2008). The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol, 10, 593-601.
15. Guo JX, Tao QS, Lou PR, et al (2012). miR-181b as a potential molecular target for anticancer therapy of gastric neoplasms. Asian Pac J Cancer Prev, 13, 2263-7.
16. Hasleton MD, Ibbitt JC, Hurst HC (2003). Characterization of the human activator protein-2gamma (AP-2gamma) gene: control of expression by Sp1/Sp3 inbreast tumour cells. Biochem J, 373, 925-32.
17. Huang F, Lin C, Shi YH, Kuerban G. (2013). MicroRNA-101 inhibits cell proliferation, invasion, and promotes apoptosis by regulating cyclooxygenase-2 in hela cervical carcinoma cells. Asian Pac J Cancer Prev, 14, 5915-20.
18. Kong D, Li Y, Wang Z, et al (2009). miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells, 27, 1712-21.
19. Korpal M, Kang Y (2008). The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis. RNA Biol, 5, 115-9.
20. Lee JW, Park YA, Choi JJ, et al (2011). The expression of the miRNA-200 family in endometrial endometrioid carcinoma.Gynecol Oncol, 120, 56-62.
21. Li Y, Van den Boom TG, Kong D, et al (2009). Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res, 69, 6704-12.
22. Liu Y, Liu Q, Jia W, et al (2013). MicroRNA-200a regulates Grb2 and suppresses differentiation of mouse embryonic stem cells into endoderm and mesoderm. PLoS One, 8, 68990.
23. Lynch J, Fay J, Meehan M, et al (2012). MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway. Carcinogenesis, 33, 976-85.
24. McPherson JD, Apostol B, Wagner-McPherson CB, et al (1997). Radiation hybrid map of human chromosome 5 with integration of cytogenetic, genetic, and transcript maps. Genome Res, 7, 897-909.
25. Osella-Abate S, Novelli M, Quaglino P, et al (2012). Expression of AP-2α, AP-2γ and ESDN in primary melanomas: correlation with histopathological features and potential prognostic value. J Dermatol Sci, 68, 202-4.
26. Park SM, Gaur AB, Lengyel E, Peter ME (2008). The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev, 22, 894-907.
27. Paterson EL, Kazenwadel J, Bert AG, et al (2013). Down-regulation of the miRNA-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates EMT is involved in cancer progression. Neoplasia, 15, 180-91.
28. Pellikainen JM, Kosma VM (2007). Activator protein-2 in carcinogenesis with a special reference to breast cancer--a mini review. Int J Cancer, 120, 2061-67.
29. Perissi V, Menini N, Cottone E, et al (2000). AP-2 transcription factors in the regulation of ERBB2 gene transcription by oestrogen. Oncogene, 19, 280-8.
30. Qiao J, Lee S, Paul P, et al (2013). miR-335 and miR-363 regulation of neuroblastoma tumorigenesis and metastasis. Surgery, 154, 226-33.
31. Saydam O, Shen Y, Wurdinger T, et al (2009). Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway. Mol Cell Biol, 29, 5923-40.
32. Soubani O, Ali AS, Logna F, et al (2012). Re-expression of miR-200 by novel approaches regulates the expression of PTEN and MT1-MMP in pancreatic cancer. Carcinogenesis, 33, 1563-71.
33. Stratmann J, Wang CJ, Gnosa S, et al (2011). Dicer and miRNA in relation to clinicopathological variables in colorectal cancer patients. BMC Cancer, 11, 345-54.
34. Su J, Zhang A, Shi Z, et al (2012). MicroRNA-200a suppresses the Wnt/β-catenin signaling pathway by interacting with β-catenin. Int J Oncol, 40, 1162-70.
35. Uhlmann S, Zhang JD, Schwager A, et al (2010). miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene, 29, 4297-306.
36. Uhlmann S, Zhang JD, Schwager A, et al (2010). miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion thanmiR-200a/141 in breast cancer. Oncogene, 29, 4297-306.
37. Williams CM, Scibetta AG, Friedrich JK, et al (2009). AP-2gamma promotes proliferation in breast tumour cells by direct repression of the CDKN1A gene. EMBO J, 28, 3591-601.
38. Woodfield GW, Horan AD, Chen Y, Weigel RJ (2007). TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling. Cancer Res, 67, 8439-43.
39. Yu Y, Wu J, Guan L, et al (2013). Kindlin 2 promotes breast cancer invasion via epigenetic silencing of the microRNA200 gene family. Int J Cancer, 133, 1368-79.